Publishing research using ab8984? Please let us know so that we can cite the reference in this datasheet
ab8984 has been referenced in 9 publications.
- Frietsch JJ et al. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. Br J Cancer : (2010).
WB;
Human.
PubMed: 20461080
- You SJ et al. Kinetic analysis of RNA interference for lamin A/C in HeLa cells. Acta Biochim Biophys Sin (Shanghai) 42:623-7 (2010).
ICC/IF;
Human.
PubMed: 20732854
- Chu Y et al. Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res 38:7736-48 (2010).
WB;
Human.
PubMed: 20675357
- Kim J et al. Cytosolic SYT/SS18 isoforms are actin-associated proteins that function in matrix-specific adhesion. PLoS One 4:e6455 (2009).
WB;
Human.
PubMed: 19649286
- Akbari M et al. Mitochondrial base excision repair of uracil and AP sites takes place by single-nucleotide insertion and long-patch DNA synthesis. DNA Repair (Amst) 7:605-16 (2008).
PubMed: 18295553
- McClintock D et al. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS ONE 2:e1269 (2007).
ICC/IF;
Human.
PubMed: 18060063
- Jones DT & Harris AL Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding. Mol Cancer Ther 5:2193-202 (2006).
PubMed: 16985052
- Glynn MW & Glover TW Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 14:2959-69 (2005).
IP.
PubMed: 16126733
- Agrelo R et al. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J Clin Oncol 23:3940-7 (2005).
PubMed: 15867203
Publishing research using ab8984? Please let us know so that we can cite the reference in this datasheet
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Western blot - Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984)
Predicted band size : 70 kDa
A. HT1080 cells + siRNA control sequence
B. HT1080 cells + siRNA Lamin
This picture was submitted by Andrea Robertson as part of a review of ab8984
Immunocytochemistry/ Immunofluorescence - Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984)
ab8984 at a 1/200 dilution staining Asynchronous and paraformaldehyde-fixed (4%) HeLa cells by immunocytochemistry. The antibody was incubated with the cells overnight and then detected using a Cy3 conjugated Goat Anti-Mouse IgG (H+L) antibody. The image shows faint, but distinct, nuclear membrane staining.
This image is courtesy of an Abreview by Kirk McManus submitted on 27 February 2006.
Western blot - Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984)
All lanes : Anti-Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984) at 1/1000 dilution
Lane 1 : 10ug HeLa whole cell lysate
Lane 2 : 50ug HeLa whole cell lysate
Lane 3 : 100ug HeLa whole cell lysate
Secondary
HRP conjugated goat anti-mouse antibody
developed using the ECL technique
Predicted band size : 70 kDa
Observed band size : 70 kDa
Exposure time : 30 seconds
This image is courtesy of an Abreview submitted by Ms Aarti Jagannath
Immunocytochemistry/ Immunofluorescence - Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984)
ab8984 staining dog skeletal muscle tissue cells by ICC/IF. Cells were fixed in methanol and incubated with ab8984, diluted 1/200, for 12 hours at 4°C. A FITC conjugated goat anti-mouse antibody, diluted 1/200, was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
Western blot - Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984)
Anti-Lamin A + C antibody [131C3] - Nuclear Envelope Marker (ab8984) at 1/100 dilution + human fibroblast at 15 µl
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 70 kDa
Lysates were prepared in RIPA buffer on ice for 30 min. They were sonicated 4 times for 5 sec prior to mixing with loading buffer.
Flow Cytometry-Lamin A + C antibody [131C3] - Nuclear Envelope Marker(ab8984)
Overlay histogram showing HeLA cells stained with ab8984 (red line). The cells were fixed with 100% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab8984, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was Mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for WB in Human (8984)
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for Western blot in Human (8984)
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for ICC/IF in Dog (8984)
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for ICC/IF in Human (8984)
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for WB in Rat (8984)
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for ICC/IF in Human (8984)
Lamin A + C antibody [131C3] - Nuclear Envelope Marker for Immunocytochemistry/ Immunofluorescence in Human (8984)
Anti-Lamin A + C antibody [131C3] - Nuclear Envelope Marker for Immunocytochemistry/ Immunofluorescence in Human (8984)
8